Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
formulary exclusions
Pharma
Lilly blows out tirzepatide sales expectations, raises guidance
In the third quarter, sales of Lilly's obesity blockbuster Zepbound reached nearly $3.6 billion, growing a staggering 185% year over year.
Fraiser Kansteiner
Oct 30, 2025 10:39am
Cigna dangles $500 to patients who switch to Lilly's Taltz
Apr 6, 2021 10:55am
Biogen, Teva benefit as payers ease up on MS meddling: analyst
Aug 30, 2018 12:25pm
Express Scripts bars 48 drugs for 2019, hitting AbbVie, Gilead
Aug 7, 2018 12:29pm
